SECURITIES AND EXCHANGE COMMISSION
Delaware |
001-31400 |
54-1345899 | ||
(State
or other jurisdiction
of
incorporation) |
(Commission
File Number) |
(IRS
Employer Identification Number) |
[
] |
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425) |
[
] |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12) |
[
] |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the exchange Act (17 CFR
240.14d-2(b)) |
[
] |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c)) |
ITEM 8.01 | OTHER EVENTS. |
Paul Cofoni, Chief Executive Officer of CACI International Inc, experienced significant chest discomfort and was admitted to the hospital on Tuesday, June 3, 2008 for treatment and evaluation. Doctors determined that he was experiencing symptoms which if not treated could have resulted in a heart attack. Late last week, following a series of tests and evaluations, doctors determined that Mr. Cofoni qualified for coronary by-pass surgery which is scheduled to occur during the week of June 9. His medical team expects that he will fully recover and return to work in approximately six weeks. During his convalescence, William M. Fairl, the President of CACI's U.S. operations, will assume, in accordance with the Company's continuity plan, the duties of Acting Chief Executive Officer and President of CACI International Inc. Dr. J. P. London continues to serve as Executive Chairman and Chairman of the Board.
CACI
International Inc |
Registrant |
By: |
|
/s/ Arnold D. Morse | |
Arnold D. Morse Senior Vice President, Chief Legal Officer and Secretary |